PMID: 8607568Oct 1, 1995Paper

Interferon-alpha treatment for severe atopic dermatitis

Allergy
H KimataK Furusho

Abstract

Patients with both severe atopic dermatitis (AD) and chronic myeloid leukemia, chronic hepatitis B, or chronic hepatitis C were treated with interferon-alpha (IFN-alpha). IFN-alpha treatment improved AD. Moreover, there were also significant decreases in serum IgE and IgG4 levels and in in vitro spontaneous IgE and IgG4 production by patients' mononuclear cells.

References

Sep 2, 1976·The New England Journal of Medicine·H B GreenbergT C Merigan
Oct 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Ruiz-MorenoV Carreño
May 26, 1990·Lancet·R M MacKie
Apr 1, 1990·The American Journal of Medicine·M BoguniewiczD Y Leung
May 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H Kimata, M Igarashi

❮ Previous
Next ❯

Citations

Mar 14, 2012·Ocular Immunology and Inflammation·Ece Turan-VuralSuphi Acar
May 15, 2001·Allergy·H Kimata
Mar 18, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Claudia ScarponiCristina Albanesi
Aug 8, 2001·Allergy·H Kimata
Jun 1, 1997·Journal of the American Academy of Dermatology·R BrehlerT A Luger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.